Effects of atorvastatin on thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.

Trial Profile

Effects of atorvastatin on thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2011

At a glance

  • Drugs Aspirin; Atorvastatin
  • Indications Embolism and thrombosis; Hypercholesterolaemia; Peripheral arterial occlusive disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 14 Jul 2011 New trial record
    • 26 May 2011 Results published in Thrombosis and Haemostasis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top